Topics

Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML

13:48 EST 4 Dec 2019 | Nature Publishing

Original Article: Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML

NEXT ARTICLE

More From BioPortfolio on "Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML"

Quick Search